Herzlich willkommen auf der DDIM-Internetseite von Ulrike Becker

Ulrike Becker
Kontaktdaten
D-45699 Herten
Kurzprofil
Werdegang (Festanstellung)
pharma-excellence
Branche: Pharma
- Ort
- Herten
Executive Consultant - pharma excellence
pharma-excellence
Branche: Pharma
- Ort
- Herten
Interim Marketing Manager Sobi Rare Benign Haematology Sep 2022- Sep 2024
Interim Marketing Manager Biocryst 2021-2023
Interim Marketing Manager Alnylam 2021-2022
Full time engagement as Patient Support Manager, Marketing Manager Hypoparathyroidsm, Marketing Manager Shrot Bowel Syndrome (Takeda, 2018 - 2021)
Basilea Pharmaceutica International Ltd
Branche: Pharma
- Ort
- Bale
Global Head of Marketing Cresemba (Antifungal)
Launching an orphan drug at hospital level (Antifungal, Haematological setting) across
Europe - direct responsibility and roll out in 6 key markets
Solving country or region-specific access issues
Forecast responsibility, supply planning responsibility
Performance: Reaching market benchmark of previously launched drugs in this specific market, with less than 10% of HQ of competitors
Overachieving (2016: 25%, 2017: 28%) budgeted sales
Biotest AG
Branche: Pharma
- Ort
- Dreieich
Pan EU reactivation of 2 key brands: Polyvalent immunoglobins used in
CMV infections (CMVIG) and Hepatitis B infections (HBIG)
In collaboration with country teams developing European product strategies and rolling out the respective activities
Performance: CMVIG: 30% ahead of previous year sales, HBIG: 18% ahead of prrevious year sales
Pfizer Inc.
Branche: Pharma
- Ort
- Brussels
Regional Marketing Director Anti-Infectives:
Marketing
Branche: Pharma
Wyeth Deutschland
- Ort
- Münster
Overall responsibility for entire hospital business (anti-infective, pain therapy, transplantation) including (7 direct reports, 56 team members)
Collaboration with market access colleagues in developing market access relevant data sets and PE dossiers
Implementation of MSL structure
Set up of complete multi-level marketing program:
Performance: Best launch and best relaunch of AI product in Europe; launch strategy rolled out across EU
Total turnover in 2004: €16 M, 2007: €34 M, 2010: €57 M
Ausbildung / Studium / Weiterbildung
TU
MSC in Genetic Engineering / Biology, TU
Kaiserslautern